샘플 요청 목록

 카트 문의
시장보고서
상품코드
1763150

세계의 자동 면역측정 분석기 시장

Automated Immunoassay Analyzers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 자동 면역측정 분석기 시장은 2030년까지 47억 달러에 달할 전망

2024년에 36억 달러로 추정되는 세계의 자동 면역측정 분석기 시장은 2024-2030년에 CAGR 4.5%로 성장하며, 2030년에는 47억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 면역 형광은 CAGR 4.7%를 기록하며, 분석 기간 종료까지 12억 달러에 달할 것으로 예측됩니다. 화학 발광 면역측정(CLIA) 분야의 성장률은 분석 기간의 CAGR로 4.3%로 추정됩니다.

미국 시장은 추정 9억 9,330만 달러, 중국은 CAGR 4.4%로 성장 예측

미국의 자동 면역측정 분석기 시장은 2024년에 9억 9,330만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 7억 5,440만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 4.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.2%와 3.7%로 예측됩니다. 유럽에서는 독일이 CAGR 4.4%로 성장할 것으로 예측됩니다.

세계의 자동 면역측정 분석기 시장 - 주요 동향과 촉진요인 정리

현대 진단에 자동 면역측정 분석기가 필수적인 이유는 무엇인가?

자동 면역측정 분석기는 생물학적 샘플의 신속하고 정확한 고처리량 검사를 가능하게 함으로써 진단 실험실에 혁명을 불러일으키고 있습니다. 이러한 장비는 혈액 및 기타 액체에 포함된 특정 단백질, 호르몬, 항체를 검출하고 정량화하는 데 매우 중요하며, 감염 진단, 종양학, 내분비학 등의 분야에서 필수적인 역할을 하고 있습니다. 의료 시스템이 조기 발견과 맞춤 의료를 우선시하는 가운데, 면역 분석은 HIV, 암, 당뇨병 등의 진단에 필수적인 툴이 되고 있습니다. 이러한 검사의 자동화는 인적 오류의 위험을 줄일 뿐만 아니라, 진단 실험실의 효율성을 높이고 수작업을 최소화하면서 대량의 샘플을 처리할 수 있게 해줍니다. 전 세계에서 진단 검사에 대한 수요가 증가함에 따라 자동 면역측정 분석기는 현대 의료에 필수적인 요소로 자리 잡고 있습니다.

기술 발전은 자동 면역측정 분석기를 어떻게 향상시키고 있는가?

기술 혁신은 자동 면역측정 분석기의 능력과 정확도를 크게 향상시켰습니다. 화학 발광 및 형광과 같은 검출 방법의 발전으로 민감도와 특이성이 향상되어 바이오마커를 더 빠르고 정확하게 검출할 수 있게 되었습니다. 또한 인공지능(AI)과 머신러닝 알고리즘을 이러한 시스템에 통합하여 복잡한 데이터의 분석과 해석을 최적화하고 임상의가 보다 정확한 진단 결정을 내릴 수 있도록 돕고 있습니다. 자동화는 시료 준비와 데이터 관리에도 적용되어 워크플로우를 더욱 간소화하고 결과 도출 시간을 단축하고 있습니다. 이러한 기술적 발전은 검사실들이 처리시간과 업무 효율성을 개선하기 위해 노력하는 가운데, 자동 면역측정 분석기의 보급을 촉진하고 있습니다.

자동면역측정장비의 사용은 어떤 규제와 컴플라이언스 기준에 의해 관리되고 있는가?

자동 면역측정 기기 시장에서는 진단 검사의 정확성과 신뢰성이 환자 치료에 직접적인 영향을 미치기 때문에 규제 당국의 모니터링이 매우 중요하며, FDA 및 유럽 의약품청(EMA)과 같은 기관은 면역측정 분석기가 시장에 출시되기 전에 안전 및 유효성 기준을 충족하는지 확인하기 위해 엄격한 지침을 시행하고 있습니다. 가이드라인을 시행하고 있습니다. 이러한 규정에 따라 제조업체는 엄격한 임상시험을 시행하고 제조 과정에서 품질관리를 유지해야 합니다. 또한 ISO 15189와 같이 의료 실험실의 능력을 규정하는 국제 표준을 준수하는 것은 이러한 시스템을 사용하는 실험실에서 검사 결과가 정확하고 신뢰할 수 있도록 보장하는 데 필수적입니다. 특히 북미나 유럽과 같이 규제가 엄격한 지역에서는 이러한 규제 프레임워크를 준수하는 것이 시장 확대에 필수적입니다.

자동 면역측정기 시장의 성장을 가속하는 요인은 무엇인가?

자동 면역측정 기기 시장의 성장은 진단 검사에 대한 수요 증가, 만성질환의 유병률 증가, 검사 효율성과 정확성을 향상시키는 기술 발전 등 여러 요인에 의해 이루어지고 있습니다. 감염, 암, 당뇨병과 같은 질병의 유병률 증가로 인해 면역측정이 중심적인 역할을 하는 고급 진단 툴의 필요성이 증가하고 있습니다. 정확한 바이오마커 검출을 필요로 하는 맞춤형 의료의 추세는 이러한 분석 장비에 대한 수요를 더욱 증가시키고 있습니다. 또한 자동화 및 AI 통합의 발전으로 실험실 생산성이 향상되어 의료 기관이 품질을 유지하면서 더 많은 검사량을 처리할 수 있게 되었습니다. 마지막으로 의료 인프라 개선에 힘입어 신흥 시장에서의 진단 검사 확대는 새로운 성장 기회를 창출하고 있습니다.

부문

최종 용도(병원, 진단 실험실, 혈액은행, 기타 최종 용도), 기술(면역 형광, 화학 발광 면역측정법(CLIA), 효소 결합 형광 면역측정법(ELFA), 효소 결합 면역 흡착 측정법(ELISA), 라디오 면역분석법(RIA), 기타 기술)

조사 대상 기업의 예

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter(UK) Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation/Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.07.10

Global Automated Immunoassay Analyzers Market to Reach US$4.7 Billion by 2030

The global market for Automated Immunoassay Analyzers estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Chemiluminescence Immunoassay (CLIA) segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$993.3 Million While China is Forecast to Grow at 4.4% CAGR

The Automated Immunoassay Analyzers market in the U.S. is estimated at US$993.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$754.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Automated Immunoassay Analyzers Market - Key Trends & Drivers Summarized

Why Are Automated Immunoassay Analyzers Vital for Modern Diagnostics?

Automated immunoassay analyzers are revolutionizing diagnostic laboratories by enabling rapid, accurate, and high-throughput testing of biological samples. These instruments are crucial for detecting and quantifying specific proteins, hormones, and antibodies in blood or other fluids, making them essential in areas such as infectious disease diagnostics, oncology, and endocrinology. As healthcare systems prioritize early detection and personalized medicine, immunoassays have become a critical tool for diagnosing conditions such as HIV, cancer, and diabetes. The automation of these tests not only reduces the risk of human error but also increases the efficiency of diagnostic labs, enabling them to process large volumes of samples with minimal manual intervention. As the demand for diagnostic testing grows globally, automated immunoassay analyzers are becoming integral to modern healthcare.

How Are Technological Advancements Enhancing Automated Immunoassay Analyzers?

Technological innovations are significantly improving the capabilities and accuracy of automated immunoassay analyzers. Enhanced sensitivity and specificity, driven by advancements in detection methods such as chemiluminescence and fluorescence, are enabling earlier and more precise detection of biomarkers. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms into these systems is optimizing the analysis and interpretation of complex data, helping clinicians make more informed diagnostic decisions. Automation is also extending to sample preparation and data management, further streamlining workflows and reducing the time required for results. As labs seek to improve turnaround times and operational efficiency, these technological advancements are driving the widespread adoption of automated immunoassay analyzers.

What Regulatory and Compliance Standards Govern the Use of Automated Immunoassay Analyzers?

Regulatory oversight is critical in the automated immunoassay analyzers market, as the accuracy and reliability of diagnostic tests directly impact patient care. Agencies such as the FDA and European Medicines Agency (EMA) enforce strict guidelines to ensure that immunoassay analyzers meet safety and efficacy standards before they are introduced to the market. These regulations require manufacturers to conduct rigorous clinical trials and maintain quality control during production. Additionally, compliance with international standards such as ISO 15189, which governs the competence of medical laboratories, is essential for labs using these systems to ensure that their test results are accurate and reliable. Adherence to these regulatory frameworks is necessary for market expansion, especially in highly regulated regions such as North America and Europe.

What Factors Are Driving the Growth of the Automated Immunoassay Analyzers Market?

The growth in the automated immunoassay analyzers market is driven by several factors, including the rising demand for diagnostic testing, the increasing prevalence of chronic diseases, and technological advancements that improve testing efficiency and accuracy. The growing incidence of infectious diseases and conditions such as cancer and diabetes is driving the need for more sophisticated diagnostic tools, where immunoassays play a central role. The trend toward personalized medicine, which requires precise biomarker detection, is further boosting demand for these analyzers. Additionally, advancements in automation and AI integration are enhancing lab productivity, allowing healthcare facilities to handle higher test volumes while maintaining quality. Finally, the expansion of diagnostic testing in emerging markets, fueled by improvements in healthcare infrastructure, is creating new opportunities for growth.

SCOPE OF STUDY:

The report analyzes the Automated Immunoassay Analyzers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Diagnostic Laboratories, Blood Bank, Other End-Uses); Technology (Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter (UK) Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation / Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Automated Immunoassay Analyzers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Driving Adoption of Immunoassay Analyzers
    • Technological Advancements in Automated Analyzers Boosting Market Growth
    • Growing Focus on Early Disease Detection Supporting Demand for Immunoassay Solutions
    • Rising Adoption in Clinical Laboratories for High-Throughput Testing Fuelling Growth
    • Expansion of Point-of-Care Diagnostics Enhancing Immunoassay Analyzer Market Demand
    • Increasing Healthcare Spending in Emerging Economies Boosting Market Opportunities
    • Rising Awareness of Personalized Medicine Supporting Use of Advanced Immunoassays
    • Growth of Infectious Disease Testing Requirements Supporting Analyzer Adoption
    • Development of Multiplex Testing Platforms Fuelling Innovations in Immunoassay Analyzers
    • Stringent Regulatory Standards for Laboratory Testing Supporting Automated Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Immunoassay Analyzers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chemiluminescence Immunoassay (CLIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Radioimmunoassay (RIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Blood Bank by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제